Connie Celum and Sinead Delany-Moretlwe

Slides:



Advertisements
Similar presentations
NIMH R34 MH82654 “A Multimedia Social Support Intervention: Adherence to HIV Care In South Africa”
Advertisements

Integration: Intersection for Reproductive Health and HIV Programs: the Kenyan Experience Family Health International Sponsored Satellite Session World.
““Improving Community Reach through Mobile Technologies: The PCI experience” ” Kwaku Yeboah, MB,CHB,MPH Vice President, HIV/AIDS Programs. PCI July 25,
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Looking back, looking forward: what we know and don’t know about oral PrEP and tenofovir gel for preventing HIV in women Jared Baeten MD PhD Departments.
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
Program Evaluation Dr. Ruth Buzi Mrs. Nettie Johnson Baylor College of Medicine Teen Health Clinic.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting Communications and Demand Creation Case Study.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
The Continuum of Participation in Research From HIV Prevention to Care: Seven Years of the iPrEx Trial Public Engagement with HIV Science.
HPTN 073: Successful Engagement of Black MSM into a Culturally Relevant Clinical Trial for PrEP Christopher Hucks-Ortiz, MPH on behalf of the HPTN Protocol.
Lulu Nair (MBChB, MPH) MTN 034/IPM 045 Protocol Chair
HIV-positive Young Transgender Women Text Me, Girl!
The Landscape of Project PrIDE Data Reporting Requirements
Logic Models How to Integrate Data Collection into your Everyday Work.
Understanding time needed to link to care and start ART
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Working with Different Groups
Anglicare Australia conference 2017
What’s Next – and When: An Update on Injectable Prevention
Aiming High – Strategies for meaningful youth participation from Link Up Jacquelyne Alesi.
A protocol in development IMPAACT Prevention Scientific Committee
On behalf of The MTN-020/ASPIRE Study Team
Promoting male partner and couples testing through secondary distribution of self-tests by pregnant and postpartum women: a randomized trial Kawango Agot1,
Chapter 18: Professional Development
ADOLESCENT PrEP STUDIES Shorai Mukaka, MBchB (UZ) 05 MAY 2017
Getting to the second 90 in adolescent HIV: What is needed
UZ-UCSF Annual Research Day 8 April 2016
Research in Social Work Practice Salem State University
MULTIPURPOSE PREVENTION TECHNOLOGY (MPT) PRODUCT PIPELINE & THEIR POTENTIAL ACCEPTABILITY AMONG ADOLESCENT GIRLS & YOUNG WOMEN Barbara Friedland, Population.
Quarraisha Abdool Karim, PhD
Coastlands Hotel – Durban, South Africa November 2016
IMPAACT 2010 Pharmacy, Study Drug, and Concomitant Medication Considerations at Entry No updates.
Provincial Evaluation Plan By Kathleen Douglas-England
WHO, UNICEF, UNFPA, UNESCO & GNP+
Provider Training Package:
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW Version: August 2018.
Antibody Mediated Prevention: HVTN 703/HPTN 081 Update
PrEP introduction for Adolescent Girls and Young Women
Tearing Down Fences HIV/STD Prevention in Rural America
Module 6: WRAPPING UP Version: August 2018.
MoH leading the design and scale up of PrEP in eswatini
Reaching those most at-risk through a general population approach: PrEP in the context of a generalized HIV epidemic Sindy Matse Eswatini Ministry of Health.
. Strategically supporting PrEP implementation for adolescents & young adults Shona Dalal, PhD 24 July
Providing PrEP to adolescents and young adults: current science
National Department of Health: South Africa
Key population-led health services (KP-LHS) critical to PrEP introduction among men who have sex with men (MSM) and transgender women (TGW) in Thailand.
HPTN 082 Uptake and adherence to daily oral PrEP as a primary prevention strategy for young African women: A Vanguard Study.
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW Version: December 2018.
Module 6: WRAPPING UP Version: December 2018.
Fatima Oliveira Tsiouris Deputy Director, Clinical & Training Unit
Participant Retention
IMPLEMETNATION OF PrEP IN SRH SETTINGS (OR CLIMBING A MOUNTAIN)
Adolescent and young people’s participation and representation in clinical trials: lessons from a community-wide HIV testing and treatment study, the HPTN.
OPTIONS 2018 HIV R4P Conference Neeraja Bhavaraju, FSG October 2018
Pediatric HIV Case Finding Strategies
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW Version: August 2018.
Module 6: WRAPPING UP Version: August 2018.
Making the Case: Ending Silos Once and For All with Evidence
Provider Training Package:
Provider Training Package:
Module 3: IMPORTANT FACTORS TO CONSIDER WHEN PROVIDING ORAL PrEP TO AGYW Version: June 2019.
Illustrative Cluster Detection and Response Strategy
Healthcare Providers’ Attitudes and Experiences Delivering Oral PrEP to Adolescent Girls and Young Women: Implementation Research to Inform PrEP Rollout.
Module 6: WRAPPING UP Version: June2019.
PrEP use in young African women in HPTN 082: Effect of drug level feedback Connie Celum, Nyaradzo Mgodi, Linda-Gail Bekker, Sybil Hosek, Deborah Donnell,
Dr Tapiwa Tarumbiswa HIV & AIDS Manager Ministry of Health Lesotho
Considerations for the standard of prevention in an evolving HIV prevention landscape
Share your thoughts on this presentation with #IAS2019
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Connie Celum and Sinead Delany-Moretlwe HPTN 082: Evaluation of daily oral PrEP as a primary prevention strategy for young African women Connie Celum and Sinead Delany-Moretlwe HPTN 082/HERS co-chairs

PrEP in Africa - key questions for implementation, esp for young women How do you create demand? What information is needed? How to communicate about a new prevention strategy (ie PrEP) in engaging, concise, non-technical ways to motivate young women in SA & Zim? How do you support PrEP delivery? How do you identify those at highest risk without creating stigma? What add’l services are needed & wanted? How do we integrate with other interventions? How do you support young women’s effective use? What does adherence support look like? Counselling, weekly SMS check-ins, clubs Drug level feedback Targeted/intensification for those who need more support?

Johannesburg & Cape Town, South Africa HPTN 082: Evaluation of daily oral PrEP as a primary prevention strategy for young African women Study Population Target Enrollment 400 women who accept PrEP at enrollment ≤ 200 women who decline PrEP at enrollment Uninfected women Ages 16-25 yrs Johannesburg & Cape Town, South Africa Harare, Zimbabwe Primary objectives: Assess the proportion and characteristics of women who accept versus decline PrEP Assess PrEP adherence using drug levels in young women

PrEP = Daily oral FTC/TDF HPTN 082 Study Design PrEP = Daily oral FTC/TDF Provide PrEP, enhanced adherence support, SOC (~200 women) Randomize PrEP Acceptors 1:1 Accept Provide PrEP, standard adherence support, SOC (~200 women) Enroll SOC and offer PrEP (≤200 women) Decline In-depth interviews about women’s decisions to use PrEP, adhere to PrEP, and acceptability in the first 3 months after PrEP acceptance. (~75 total, including acceptors and decliners) Standard Adherence Support Enhanced Adherence Support CBT counseling SMS texting Adherence clubs Drug level feedback counseling

Primary Objectives of HPTN 082 To assess the proportion and characteristics of young HIV-uninfected women who accept versus decline PrEP. To assess the difference in PrEP adherence in young women randomized to enhanced adherence support (using drug level feedback) versus standard of care adherence support.

Secondary Objectives Timing of PrEP acceptance among women who initially decline PrEP at enrollment but elect to accept PrEP during follow up. Correlates of early and delayed acceptance of PrEP. Correlates of PrEP adherence at Weeks 13, 26, and 52. Proportion who discontinue PrEP, timing, & factors associated with PrEP discontinuation. Specificity and predictive value of a PrEP readiness tool (based on the HIV Prevention Readiness Measure, HPRM) to predict uptake and adherence to oral PrEP.

Secondary objectives (continued) Qualitative factors that influence women’s decisions to use PrEP, to adhere to PrEP, and acceptability of PrEP in the first 3 months after PrEP acceptance. Adverse events between women on PrEP and women not taking PrEP. HIV incidence in those who accept PrEP compared to those who do not. And assess the association with detectable TFV in PrEP users who acquire HIV infection during the study.

Clinical Research Sites Emavundleni, Cape Town Ward 21, Wits RHI, Johannesburg Spilhaus, Harare

Behavioral data collection (CASI) Partnership characteristics & partner’s HIV status Sexual behaviors HIV risk perception HIV stigma PrEP readiness (HPRM) Future orientation and aspirations; self-efficacy Alcohol and drug use Gender-based violence Disclosure to peers, family members, teachers, and partner(s) about PrEP use and participation in the study

Qualitative interviews (25 per site, 75 total) Initial PrEP ‘decliners’ about: Factors that influence women’s uptake of PrEP 2) PrEP acceptors Women who have high or low adherence based on drug levels at 1 & 2 months Factors that influence adherence to PrEP (e.g., storage of product, disclosure, communication with partner, alcohol & drug use) Among those randomized to get drug level feedback, their experience & how feedback influenced subsequent PrEP adherence

Get PrEPed! Educational video Young women screening for HPTN 082 shared the video with peers on social media Explains PrEP using youth-friendly graphics Filmed and edited by Umuzi (South Africa) Script, graphics and film developed in collaboration with and evaluated by youth in South Africa and Zimbabwe https://www.youtube.com/watch?v=tt-O4ZORrYQ Young women have less questions about how PrEP works after viewing the video in the waiting room

HPTN 082: Adherence Support Counselling Weekly SMS Adherence clubs Drug Level Feedback Standard Enhanced

Discrete, non-medial product storage Pill cases & carrying bags

Hey sister, howzit? Are you ok? Weekly SMS PrEP accepters will receive weekly SMS text messaging until Week 13, with the option to continue throughout follow up if desired Hey sister, howzit? Are you ok?

HPTN 082 Two-way SMS Friendly user interface to send weekly SMS check-ins Modeled after WelTel program which increased ART adherence in Kenya (Lester, Lancet 2010) Provides a “check-in” with participants during first 13 weeks on PrEP Transmission data will be collated to determine who & which women respond with concerns Will evaluate outcomes of call-backs

HPTN 082 Adherence Clubs Develop peer support Sharing of PrEP motivations & experiences Address concerns about PrEP & adherence Staff & participants openly discuss issues Opportunity to address rumors & myths Problem-solve adherence challenges High acceptability & engagement

Drug level feedback in enhanced arm 4 or more doses per week Key message: You are doing really well! Keep up the good work and remember that taking one PrEP pill every day is needed for strong protection against HIV. 1-3 doses per week Key message: It looks like you are trying to take the PrEP pills, but may have missed some doses. Remember that taking one pill every day is needed for strong protection against HIV. How can we help you do even better? Undetectable Key message: It looks like you haven’t been able to take the PrEP pills. Is PrEP something that you are still interested in? If yes, how can we help you? ENR Week 4 Week 8 Week 13

Challenges of enrolling minors Parents are a key stakeholder group May be gatekeepers for PrEP use Are an important constituency to engage with irrespective of IRB requirements IRBs are sometimes ahead of regulations in willingness to allow 16 & 17 yr olds to participate without parental consent

IRB requirements for parental consent Different consent and risk/benefit considerations for a known efficacious product, such as oral PrEP Need to continue to develop acceptable & innovative approaches to enrolling late adolescents in HIV prevention research Simpler description of side effects Interactive & graphic consent methods

HPTN 082 Status Enrollment is almost complete 354 (89%) of the target 400 women who accept to enroll PrEP Only 9% (36/390) women declined PrEP at enrollment Capped at 200 A substantial proportion subsequently initiated PrEP Based on present rates of enrollment, all sites will be fully enrolled by August 2017

Youth CABs had substantial input Reviewed study documents including informed consents, content/handle for 2 way SMS Provided input and feedback on: What is PrEP video? Messages and materials Logo Suggested ways to make the adolescent clinic comfortable and appealing Youth Community Advisory Board

Stakeholder engagement is key & needs to be ongoing PrEP & Women Consultation – June 2016 Important for demand creation in communities PrEP information is not publicly available PrEP access is limited to demo projects & research projects Presenting on PrEP and HIV prevention at Community Events, such as TAC Youth Dialogue

HPTN 082 definitions of success PrEP is new in these communities Will learn from early adopters & PrEP decliners Women will self-sort in terms of PrEP uptake & continuation High adherence among women who persist beyond 3 months of PrEP use Peers & parents influence PrEP uptake & adherence Anticipate that some ’PrEP initiators’ will decide that they don’t want to continue Early discontinuation is OK

We thank the youth CABs for their ideas and feedback We thanks the young women who are participating in HPTN082/HERS